Prime Medicine (PRME) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.46
-0.41
-0.36
-0.31

Details

Expected EPS
-0.313453
Actual EPS
-0.4
Surprise EPS
-0.09
Surprise Percent
+27.61%

Description

Prime Medicine (PRME) has reported earnings of -0.4 per share for Q2 2025.

0 Comments

Share your thoughts